A4: patient weight is not available.Per the gore® cardioform asd occluder instruction for use, in the section ¿potential device ¿ or procedure-related adverse events¿.Adverse events associated with the use of the occluder may include, but are not limited to: device embolism.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.
|
It was reported the physician implanted a 48mm gore® cardioform asd occluder to close an atrial septal defect.Later that evening the device embolized.The next day, the device was removed in an additional transcatheter procedure, and the defect was closed surgically.The patient was doing well post surgery.
|